Immunology tests in Dubai & UAE

Compare available Immunology tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

271

Listed price range

450.00–40,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Immunology test prices

Showing 121–135 of 271 matching tests.

Immunology diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-1600 HLA DNA High Resolution Typing Test This test identifies specific HLA-DRB1 gene variants using high-resolution DNA sequencing.	Blood (EDTA/ACD) or Buccal Swab	10–12 working days	1,200.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["HLA-DRB1 gene allele variants", "Human Leukocyte Antigen (HLA) compatibility"] Parameters [] Preparation ["No fasting or special preparation is needed.", "You can eat and drink normally before the sample draw."] Indications ["Organ transplantation compatibility assessment", "Bone marrow transplantation compatibility assessment", "Autoimmune disease risk assessment (e.g., celiac, Type 1 diabetes)", "Pharmacogenomic profiling"] Measurement technique Confirm with laboratory Codes LOINC: 86206-4 ICD-10: Z13.83 Clinical summary This test identifies specific HLA-DRB1 gene variants using high-resolution DNA sequencing.
TEST-1608 HLA DNA Typing for Bone Marrow Transplant (10 Antigens) PCR Test This test evaluates 10 critical Class I & II HLA antigens (HLA-A, B, C, DR, DQ) using high-resolution SSP-PCR technology.	Peripheral whole blood	10–12 working days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["HLA-A alleles", "HLA-B alleles", "HLA-C alleles", "HLA-DR alleles", "HLA-DQ alleles"] Parameters [] Preparation ["No special preparation required", "Continue all prescribed medications"] Indications ["Pre-bone marrow transplant donor/recipient matching", "Unrelated donor selection"] Measurement technique Confirm with laboratory Codes LOINC: 10320-2 ICD-10: Z94.81, Z52.0, Z01.89 Clinical summary This test evaluates 10 critical Class I & II HLA antigens (HLA-A, B, C, DR, DQ) using high-resolution SSP-PCR technology.
TEST-1612 HLA DNA Typing for Kidney / Liver Transplant (PCR, Reverse SSOP Test This test identifies specific Human Leukocyte Antigen (HLA) alleles in a patient's DNA to assess compatibility for organ transplantation.	Peripheral Whole Blood	10 – 12 Days	2,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Human Leukocyte Antigen (HLA) alleles", "Histocompatibility"] Parameters [] Preparation ["Prescription required.", "Donor/recipient photos required.", "Form 33 consent required."] Indications ["Pre-transplant histocompatibility testing for kidney transplant", "Pre-transplant histocompatibility testing for liver transplant"] Measurement technique Confirm with laboratory Codes LOINC: 88235-6 ICD-10: Z94.0, Z94.4 Clinical summary This test identifies specific Human Leukocyte Antigen (HLA) alleles in a patient's DNA to assess compatibility for organ transplantation.
TEST-1631 HLA DNA Typing High Resolution (NGS) Test This test provides a detailed analysis of the HLA genes, identifying specific alleles crucial for transplant compatibility.	Whole Blood (Lavender Top EDTA)	10-12 Days	1,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["HLA Class I alleles", "HLA Class II alleles"] Parameters [] Preparation [] Indications ["Pre-transplant donor-recipient matching", "Evaluation of transplant rejection", "Identification of novel alleles"] Measurement technique Confirm with laboratory Codes LOINC: 81285-6 ICD-10: Z01.818 Clinical summary This test provides a detailed analysis of the HLA genes, identifying specific alleles crucial for transplant compatibility.
TEST-1635 HLA DSA (Donor Specific IgG Antibodies) Class I & II Test This diagnostic test evaluates the presence and level of donor-specific IgG antibodies against HLA Class I and Class II antigens in a transplant recipient's serum.	Serum (peripheral venous blood)	10–12 calendar days from sample receipt	1,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Donor-specific IgG antibodies (DSA)", "Antibody levels against HLA Class I (A, B, C) and Class II (DR, DQ, DP) antigens"] Parameters [] Preparation ["Continue all prescribed immunosuppressive medications unless directed otherwise by your transplant physician."] Indications ["Pre-transplant immunological risk assessment", "Post-transplant monitoring for antibody-mediated rejection", "Evaluation of unexplained graft dysfunction"] Measurement technique Confirm with laboratory Codes LOINC: ['48319-8', '48320-6'] ICD-10: ['Z94.0', 'T86.1'] Clinical summary This diagnostic test evaluates the presence and level of donor-specific IgG antibodies against HLA Class I and Class II antigens in a transplant recipient's serum.
TEST-1616 HLA DSA-SAB Class II IgG Antibodies with C1q Screen Test This test detects and quantifies donor-specific IgG antibodies against HLA class II antigens, assessing their potential to activate complement.	Serum (peripheral blood)	10-12 Business Days	4,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Donor-specific IgG antibodies against HLA Class II (DR, DQ, DP)", "Complement-fixing capacity via C1q binding"] Parameters [{"name": "HLA Class II DSA IgG (DR, DQ, DP)", "reference_range": "Negative"}, {"name": "C1q Binding", "reference_range": "Negative"}] Preparation ["No specific fasting required", "Continue all prescribed medications unless otherwise instructed by your physician"] Indications ["Pre-transplant immunologic risk assessment", "Post-transplant antibody-mediated rejection (AMR) monitoring", "Guiding immunosuppressive strategies"] Measurement technique Confirm with laboratory Codes LOINC: 93336-2 ICD-10: Z94.0 Clinical summary This test detects and quantifies donor-specific IgG antibodies against HLA class II antigens, assessing their potential to activate complement.
TEST-3004 HLA DSA‑SAB Class I IgG Antibodies with C1q Screen Test This test evaluates the presence and complement-fixing capacity of donor-specific IgG antibodies against Class I HLA antigens in transplant recipients.	Serum (peripheral blood)	10–12 business days	4,300.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Donor-specific IgG antibodies against Class I HLA antigens", "Complement-fixing capacity of detected antibodies (C1q binding)"] Parameters [] Preparation [] Indications ["Solid organ transplant recipients", "Monitoring for antibody-mediated rejection", "Risk stratification for immunosuppression adjustments"] Measurement technique Confirm with laboratory Codes LOINC: 94716-4 ICD-10: Z94.0 Clinical summary This test evaluates the presence and complement-fixing capacity of donor-specific IgG antibodies against Class I HLA antigens in transplant recipients.
TEST-1639 HLA Hypersensitivity to Abacavir (B57:01) Test This test identifies the presence or absence of the HLA-B57:01 gene variant, which is strongly associated with hypersensitivity reactions to the medication abacavir.	Whole blood (EDTA) or buccal swab	10–12 business days from sample receipt	1,200.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Presence of HLA-B57:01 allele", "Genetic susceptibility to abacavir hypersensitivity"] Parameters [{"name": "HLA-B57:01 Allele", "reference_range": "Negative / Positive"}] Preparation ["No fasting required", "No specific medication or diet restrictions"] Indications ["Mandatory screening before initiating abacavir therapy", "Patients diagnosed with HIV"] Measurement technique Confirm with laboratory Codes LOINC: 52091-3 ICD-10: Z01.818 Clinical summary This test identifies the presence or absence of the HLA-B*57:01 gene variant, which is strongly associated with hypersensitivity reactions to the medication abacavir.
TEST-1622 HLA Mixed Antibody Screen Test This test detects and quantifies circulating antibodies against HLA Class I, Class II, and MICA antigens in a patient's serum.	Serum	10–12 business days	1,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Anti-HLA Class I antibodies", "Anti-HLA Class II antibodies", "Anti-MICA antibodies", "Mean Fluorescence Intensity (MFI) values"] Parameters [{"name": "Anti-HLA Class I Antibodies", "reference_range": "Negative or low MFI"}, {"name": "Anti-HLA Class II Antibodies", "reference_range": "Negative or low MFI"}, {"name": "Anti-MICA Antibodies", "reference_range": "Negative or low MFI"}] Preparation ["No specific fasting required", "Inform lab of current medications, especially immunosuppressants"] Indications ["Pre-transplant evaluation", "Post-transplant monitoring", "Evaluation of potential transplant recipients", "Assessment of immunologic risk"] Measurement technique Confirm with laboratory Codes LOINC: 48349-2 ICD-10: Z01.818 Clinical summary This test detects and quantifies circulating antibodies against HLA Class I, Class II, and MICA antigens in a patient's serum.
TEST-1605 HLA Panel Reactive IgG Antibodies (PRA) Class I Quantitative Test This test quantifies the percentage of IgG antibodies against HLA Class I antigens in serum, indicating pre-transplant sensitization.	Serum	10–12 business days	2,200.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Anti-HLA Class I IgG antibodies", "Panel Reactive Antibody (PRA) percentage"] Parameters [] Preparation ["Collect sample at least 48 hours post-dialysis", "No fasting required"] Indications ["Pre-transplant evaluation for solid organ transplant (renal, cardiac)", "Assessment of pre-transplant sensitization", "Donor selection guidance"] Measurement technique Confirm with laboratory Codes LOINC: 29453-7 ICD-10: Z94.9 Clinical summary This test quantifies the percentage of IgG antibodies against HLA Class I antigens in serum, indicating pre-transplant sensitization.
TEST-1586 HLA Panel Reactive IgG Antibodies (PRA) Screen Test This test quantifies the percentage of pre-formed IgG antibodies against a panel of human leukocyte antigens (HLA). It is a critical tool for assessing immunological risk before so...	Serum (Standard Peripheral Whole Blood)	10–12 Business Days	1,200.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Percentage of Panel Reactive IgG Antibodies (PRA%)", "Presence and specificity of anti-HLA IgG antibodies"] Parameters [{"name": "Panel Reactive Antibody (PRA) Percentage", "reference_range": "Varies by laboratory; typically Preparation ["No special dietary restrictions required.", "Blood collection ideally performed 48 hours after a dialysis session if on hemodialysis.", "Inform phlebotomist about recent blood transfusions, IVIG therapy, or rituximab administration."] Indications ["Pre-transplant evaluation for solid organ transplantation", "Pre-transplant evaluation for hematopoietic stem cell transplantation", "Assessment of immunological sensitization"] Measurement technique Confirm with laboratory Codes LOINC: 34637-6 ICD-10: Z01.818 Clinical summary This test quantifies the percentage of pre-formed IgG antibodies against a panel of human leukocyte antigens (HLA). It is a critical tool for assessing immunological risk before solid organ or hematopoietic stem cell transplantation.
TEST-1648 HLA Pre-Transplant Workup (Non-Sensitized Recipient Panel) Test This test evaluates HLA compatibility between a non-sensitized transplant recipient and a potential donor to predict the risk of hyperacute rejection.	Whole blood (ACD, SST, EDTA tubes)	10–12 business days	2,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Human Leukocyte Antigens (HLA) compatibility", "Donor-Specific Antibodies (DSA)", "HLA Allele Mismatches"] Parameters [{"name": "CDC Crossmatch", "reference_range": "Negative"}, {"name": "Luminex X-Map DSA", "reference_range": "Undetectable"}] Preparation ["Schedule collection at least 48 hours after last dialysis session", "Remain well-hydrated", "Have prescription, signed consent form, and photographs ready"] Indications ["Pre-kidney transplantation assessment", "Evaluation of immunological risk in non-sensitized recipients"] Measurement technique Confirm with laboratory Codes LOINC: 48669-3 ICD-10: Z01.81 Clinical summary This test evaluates HLA compatibility between a non-sensitized transplant recipient and a potential donor to predict the risk of hyperacute rejection.
TEST-1642 HLA Pre-Transplant Workup (Sensitized Recipient Panel 5) Test This test detects and characterizes donor-specific antibodies (DSAs) against HLA antigens in a sensitized transplant recipient.	Peripheral Blood (Whole Blood, Serum)	10–12 business days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Donor-Specific Antibodies (DSAs)", "HLA Class I Antibodies", "HLA Class II Antibodies"] Parameters [] Preparation ["Provide blood samples in specified collection tubes", "Physician prescription required", "Valid identification documents required", "Signed consent form required"] Indications ["Pre-transplant evaluation for sensitized recipients", "Patients with history of prior transplantation", "Patients with history of blood transfusion", "Patients with history of pregnancy"] Measurement technique Confirm with laboratory Codes LOINC: 54478-2 ICD-10: Z02.83 Clinical summary This test detects and characterizes donor-specific antibodies (DSAs) against HLA antigens in a sensitized transplant recipient.
TEST-1662 HLA Pre‑Transplant Workup (Sensitized Recipient Panel 5) Test This test evaluates the presence and specificity of anti-HLA antibodies in a patient's serum, crucial for assessing transplant compatibility and rejection risk.	Serum (SSTs), EDTA whole blood, Sodium Heparin whole blood	10–12 working days	5,100.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Anti-HLA antibodies (complement-fixing and non-complement-fixing)", "Donor-Specific Antibodies (DSAs)"] Parameters [] Preparation ["Collection preferably performed 48 hours after dialysis", "Inform laboratory of recent IVIg or rituximab administration"] Indications ["Patients awaiting solid organ transplantation", "Sensitised transplant candidates", "Pre-transplant immunological assessment"] Measurement technique Confirm with laboratory Codes LOINC: 97489-7 ICD-10: Z94.9, Z13.9 Clinical summary This test evaluates the presence and specificity of anti-HLA antibodies in a patient's serum, crucial for assessing transplant compatibility and rejection risk.
TEST-1669 HLA Single Antigen Bead Assay (DSA‑SAB) for Class I & II IgG Antibodies Test This test detects and measures donor-specific anti-HLA Class I and II IgG antibodies in serum.	Serum	10–12 working days	8,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Donor-specific anti-HLA Class I IgG antibodies", "Donor-specific anti-HLA Class II IgG antibodies", "Mean Fluorescence Intensity (MFI)"] Parameters [{"name": "Mean Fluorescence Intensity (MFI)", "reference_range": null}] Preparation ["No fasting required", "Continue prescribed immunosuppression unless advised otherwise by physician", "Provide brief clinical history, transplant date, donor specifics, and recent medication changes"] Indications ["Pre-transplant assessment of sensitization", "Post-transplant monitoring for de novo DSA", "Evaluation of suspected antibody-mediated rejection", "Guiding immunosuppression therapy"] Measurement technique Confirm with laboratory Codes LOINC: 10364-5 ICD-10: Z94.0 Clinical summary This test detects and measures donor-specific anti-HLA Class I and II IgG antibodies in serum.

Category overview

Immunology: overview

When your immune system requires closer attention, obtaining precise answers is the first step toward safeguarding your overall well-being and finding peace of mind. At DNA Labs UAE, our Immunology department utilizes highly advanced automated assay systems to evaluate your body's defense mechanisms. From identifying potential immunodeficiencies to analyzing complex autoimmune responses, our comprehensive immunology testing in the UAE equips your doctor with the vital data needed for effective medical guidance. As one of the most trusted diagnostic labs in Dubai and the UAE, we guarantee strict patient confidentiality alongside fast, highly accurate turnaround times. Take a proactive approach to your immune health today. Browse our immunology diagnostics below, schedule a secure home sample collection, or contact our medical specialists to book your appointment.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area

Immunology tests in Dubai & UAE

Immunology test prices

Immunology: overview

Use the test details as a conversation starter

Related Immunology categories